Abbott's MDx Sales Rise 4 Percent in Q4
January 23, 2013
Abbott's MDx Sales Rise 4 Percent in Q4
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Dx Focus: Inostics OncoBEAM Blood Test; Abbott RealTime HPV Test; BioMérieux THxID BRAF assay
May 30, 2013 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Trovagene's Q4 Revenues, Loss Rise
April 2, 2013 / GenomeWeb Daily News - Study Vets Abbott Plex-ID Platform as Tool for Broad Fungal ID Directly from Clinical Specimens
March 28, 2013 / PCR Insider - Epigenomics' 2012 Revenues Dip 29 Percent
March 21, 2013 / GenomeWeb Daily News